Long-standing diabetes mellitus is characterized by the development of widespread micro-and macroangiopathy. The Two weeks of LY333531 treatment at three oral doses (0-1, 1 or 10mg/kg) showed no apparent toxicity, and no effect on body weight and blood glucose in controls and in diabetic rats. Low dose treatment (0-lmg/kg) was sufficient to return PKC activity in the retina to normal in diabetic rats and had no effect in the non-diabetic animals. Concomitantly, it induced a significant (70%) decrease in retinal mean circu¬ lation time. In the renal glomeruli, PKC was signifi¬ cantly reduced only with high doses of LY333531. This high dose treatment could also normalize the renal glomerular filtration rate, one of the earliest abnor¬ malities of renal dysfunction. After 8 weeks of treat¬ ment, albumin excretion rate was also significantly lowered.
Long-standing diabetes mellitus is characterized by the development of widespread micro-and macroangiopathy. The 
